VHL vitasora health limited

Virax is to a receive a milestone payment from their Co-X-Gene...

  1. 12 Posts.
    Virax is to a receive a milestone payment from their Co-X-Gene Technology licence agreement with Transgene (France) thanks to Transgene's partnership agreement with Roche.

    From Transgene's announcement, it looks as though further payments can be expected in both the short and long term.

    Further confirmation of Transgene's product utilising the technology will support Virax in their proof of product.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.7¢
Change
0.000(0.00%)
Mkt cap ! $46.40M
Open High Low Value Volume
2.8¢ 2.8¢ 2.6¢ $2.624K 96.30K

Buyers (Bids)

No. Vol. Price($)
1 28618 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 273136 1
View Market Depth
Last trade - 15.59pm 11/09/2025 (20 minute delay) ?
VHL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.